BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs4950928, GATA1, calcium channel activity, Allergy to pollen, Endothelial cell)
Bookmark Forward

QuickView for Nup98 (gene)


Body Atlas

Most Correlated Tissues

  1. Testes
  2. Eosinophil of peripheral blood
  3. Leukocyte (polymorphonuclear) of peripheral blood
  4. Hematopoietic stem cell of bone marrow
  5. Peritoneum
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Viral disease
  2. Liver transplant disorder
  3. Disease due to Orthopoxvirus
  4. Streptococcal infectious disease
  5. Infestation by Ixodidae
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Cefoxitin
  2. tyloxapol
  3. chrysin
  4. Apigenin
  5. nipecotic acid
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Idd1
  2. Idd5
  3. MIR98
  4. BEX2
  5. TLR3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Misregulation of Nucleoporins 98 and 96 leads to defects in protein synthesis that promote hallmarks…
  2. Nup98 promotes antiviral gene expression to restrict RNA viral infection in Drosophila.
  3. Vesiculoviral matrix (M) protein occupies nucleic acid binding site at nucleoporin pair (Rae1 • Nup9…
  4. Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.
  5. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia
  2. TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatu…
  3. The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid …
  4. A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
  5. Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.